Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
GLP-1 Therapies and Risk of Muscle Loss Glucagon-like peptide-1 (GLP-1) medications have increasingly been prescribed to treat cardiometabolic conditions such as obesity, diabetes, and cardiovascular diseasesYeo et al (2024) conducted a nationwide analysis on the usage of GLP-1's in patients without diabetes and observed a 700% (from 21,000 in 2019 to 174,000 in 2023) increase between the years 2019-2023
Researchers saw a similar discontinuation rate in clinical trials of tirzepatide
Hashimoto K
The predictive model developed in this study highlights the importance of considering individual patient characteristics and medication interactions when prescribing GLP-1 M drugs
Past issues with your pancreas (pancreatitis) or kidneys
US$ 23.80
US$ 20.41
US$ 26.04
US$ 21.38
US$ 20.39
US$ 29.31
US$ 28.63
US$ 21.03
US$ 22.90
US$ 21.16
US$ 24.42
